Impactimmunotherapy.com

Visit impactimmunotherapy.com
  • 8 months ago

    Last scanned

  • 7 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Impactimmunotherapy.com

Visit impactimmunotherapy.com

Overal rating:

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

Immunotherapy Progress and Clinical Treatments

With the approval of drugs like Nivolumab and Pembrolizumab patients are already feeling the impact of cancer immunotherapy. Still, with each step forward researchers are becoming increasingly aware of the complexity and unique challenges that come with each individual’s disease. Given that not all patients respond to existing treatments, there is an enormous need to start looking at the next generation of immunotherapy solutions. At Cambridge He...

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Liquid Web, L.L.C, which reserves the following IP addresses for impactimmunotherapy.com: 205.174.26.165. Moreover, DNS used with this website include ns85.worldnic.com, ns86.worldnic.com. Subnet identifier ranges from 205.174.24.0 to 205.174.27.255. Classless Inter-Domain Routing (CIDR) is 205.174.24.0/22. ARIN net type is Direct Allocation.

  • 8 months ago

    Last scanned

  • 7 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Network

ADDRESSING DETAILS

Whois

OWNERSHIP

Domain & Keywords

The registrar of impactimmunotherapy.com is Network Solutions, LLC and the name expires on 2024-03-28. According to open source data, you can reach the owner at cwhite@healthtech.com but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.

  • clinical
  • progress
  • cancer
  • and
  • Immunotherapy
  • immuno-oncology
  • neoantigens in cancer immunotherapy

Websites similar to impactimmunotherapy.com